FDA Approves Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void For Patients With Life-Altering Fecal (Bowel) Incontinence
Links shared publicly online about this topic.
- 250total visits
FDA Approves Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void For Patients With Life-Altering Fecal (Bowel) Incontinence
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, announced that the U.S. Food and Drug Administration (FDA) has appr
View full resource at medicalnewstoday.com
Tags: Incontinence, Diet and Nutrition, Drug, FDA, Bladder Dysfunction
Most Recently Shared on June 1, 2011 at 4:05 pm By:
FDA Approves Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void For Patients With Life-Altering Fe... http://mnt.to/3WCy
Also Shared By:
Advertisement
MNT Drug Approvals
@mnt_drugapprov
FDA Approves Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void For Patients With Life-Altering Fe... http://mnt.to/3WCy
1 year ago...